An association between nuclear morphology and immunohistochemical expression of p53 and p16INK4A in lung cancer cells

Medical Molecular Morphology

Volumn 47, Issue 3, 2014, Pages 130-136

  Okudela, Koji ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromatin density; Lung cancer; Nuclear atypia; Nuclear size; p16INK4A; p53

Indexed keywords

EID: 84883671774     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0052-x     Document Type: Article

References (24)

1. Kumar V, Cotran RS (1992) Basic pathology. In: Robbins SL (ed). W.B. Sounders Company, Philadelphia
2. D’Errico M, Calcagnile AS, Corona R, Fucci M, Annessi G et al (1997) p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res 57:747–752
3. Dalton WB, Yu B, Yang VW (2010) p53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene 29:1929–1940
4. Duensing A, Duensing S (2010) Centrosomes, polyploidy and cancer. Adv Exp Med Biol 676:93–103
5. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) Pathology and genetics—tumors of the lung, pleura, thymus and heart, IARC Press, Lyon. In: WHO (ed). IARC Press, Lyon
6. Okudela K, Woo T, Mitsui H, Yazawa T, Shimoyamada H et al (2010) Morphometric profiling of lung cancers-its association with clinicopathologic, biologic, and molecular genetic features. Am J Surg Pathol 34:243–255
7. Bodner SM, Minna JD, Jensen SM, D’Amico D, Carbone D et al (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743–749
8. Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K (2004) Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication. Oncol Rep 12:389–395
9. McGee JO, Isaacson PG, Wright NA (1992) Principles of pathology. In: Wright NA (ed). Oxford University Press, Oxford
10. Alberts B, Bray D, Lewis J, Martin R, Roberts K, et al. (1994) Molecular Biology of the Cell. In: Watson JD (ed). Garland Publishing, New York
11. Thompson SL, Bakhoum SF, Compton DA (2010) Mechanisms of chromosomal instability. Curr Biol 20:R285–R295
12. Thompson SL, Compton DA (2010) Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 188:369–381
13. Paolo D’Avino P (2009) How to scaffold the contractile ring for a safe cytokinesis—lessons from Anillin-related proteins. J Cell Sci 122:1071–1079
14. Li J, Wang J, Jiao H, Liao J, Xu X (2010) Cytokinesis and cancer: Polo loves ROCK‘n’ Rho(A). J Genet Genomics 37:159–172
15. Guasconi V, Souidi M, Ait-Si-Ali S (2005) Nuclear positioning, gene activity and cancer. Cancer Biol Ther 4:134–138
16. Cremer T, Cremer M, Dietzel S, Muller S, Solovei I et al (2006) Chromosome territories–a functional nuclear landscape. Curr Opin Cell Biol 18:307–316
17. Weichert W (2009) HDAC expression and clinical prognosis in human malignancies. Cancer Lett 280:168–176
18. Luczak MW, Jagodzinski PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44:143–154
19. Au Yeung CL, Tsang WP, Tsang TY, Co NN, Yau PL et al (2010) HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep 24:1599–1604
20. Esteller M (2005) Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 45:629–656
21. Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med 11:687–694
22. Bunney TD, Katan M (2010) Phosphoinositide signalling in cancer: beyond PI3 K and PTEN. Nat Rev Cancer 10:342–352
23. Kondo M, Yokoyama T, Fukui T, Yoshioka H, Yokoi K et al (2005) Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery. Lung Cancer 50:385–391
24. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988–993